This week, Prof. Monica Slavin & Dr. Abby Douglas were invited guests at #Tandem26 (ASTCT & @cibmtr.bsky.social ) in Salt Lake City. Monica presented Challenging Cases in Transplant & Abby debated- Is Advanced Imaging in ID Worth the Cost? (“Con”).
Recently published: updated consensus guidelines for the management of neutropenic fever
✔️Now includes recommendations for paediatric patients
✔️Scope broadened from Australian guidelines to Australasian
✔️Addition of new chapters (see thread)
Read guidelines: onlinelibrary.wiley.com/toc/14455994...
Recently, @michyong.bsky.social presented at the 9th Annual #ICBMT2025 in Busan, Korea on CMV Infection in Allogeneic HSCT: Risk Stratification and Prevention, focused on advances in prophylaxis for CMV management after allogeneic hematopoietic stem cell transplantation- Congratulations!
he NCIC September newsletter is out! 📢
Read all about our research updates, recent publications and upcoming events: cancerandinfections.org/newsletter
Australia’s first multi-site study of infections in cancer & transplant patients, PROSPER, is now published in BMJ Open! It will guide future infection prevention & control for this vulnerable group.
Read the full article here: bmjopen.bmj.com/content/15/7...
Pleased to publish the INTERACT study - describing current infection prevention & surveillance practice in the care of Australasian cancer/transplant patients & areas for future research (& thankful to all who participated) 🌟 @ncicancer.bsky.social #TxID #IDSky
www.ajicjournal.org/article/S019...
You're invited to the NCIC Showcase!
Learn about our work in infection & cancer care through rapid 2-min talks from clinicians, scientists & more.
📅 7 Aug | 🕧 12:30–2PM | 🏢 PMCC & Teams
🍽️ Lunch/tea included
Register here: cancerandinfections.org/ncic-showcase
Join us for the Asia Fungal Working Group and ASID's ANZMIG Fungal Frontier Asia Pacific webinar on Emerging Dermatophyte Infections: Arrival of Antifungal Drug Resistance.
📅 Date: 3rd of September
⌚ Time: 19.30 AEST
📍 Location: Online
👉 Register here: asidevents.eventsair.com/anzmig-2025-...
📰 July Newsletter is Out Now!
Catch up on the latest updates, research highlights, and upcoming events.
📖 Read it here: cancerandinfections.org/newsletter
2 WEEKS AWAY
Join us for this hybrid event on Friday July 25th in Melbourne where we will hear updates in candida and other yeast clinical and laboratory diagnosis and management, as well the "ins and outs" of the Australasia Candidaemia Study III.
Register: cancerandinfections.org/acsiii-regis...
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial url: academic.oup.com/jid/article-...
Sign up today on our website: cancerandinfections.org
We were proud to be well represented at the inaugural The
Transplantation Society of Australia and New Zealand Infectious Disease Day on 20 June 2025 — a fantastic event co-badged with ASID Immunocompromised Host Special Interest Group.
New Publication!
Professor Monica Slavin - “Very pleased to be part of this important study of olorofim, a novel antifungal drug for difficult-to-treat fungal infections. It was active against infections resistant to or failing existing treatments and offers a much-needed option for our patients.”
Pleased to present our subgroup analysis @TSANZ. Would IPC specific to the SOT cohort be valuable? Which HAIs/OIs should we monitor, and how do we build a national framework for success? @ncicancer.bsky.social #TxID #IDSky
Today, Belinda Lambros, presented on the Nursing Considerations from the Australasian Consensus Guidelines for Neutropenic Fever 2024 update at the 2025 Cancer Nurses Society Of Australia (CNSA) and International Society of Nurses in Cancer Care ISNCC congress.
Happy Friday!
The June edition of the NCIC Newsletter is now live.
To read, please visit: cancerandinfections.org/newsletter
We're Hiring!
2026 Peter MacCallum Cancer Centre ID Registrar
This is a fully accredited advanced trainee position for an ID physician looking for further training in the Immunocompromised Host, based at the Peter MacCallum Cancer Centre.
Learn more: careers.petermac.org/job/MELBOURN...
This week, we said farewell to Enric, our visiting research fellow from Spain, who spent the past three months with us. We wish him all the best in his future endeavors!
Learn more about our visiting fellow program: cancerandinfections.org/visiting-fel...
Join us next Wednesday for the Asia Fungal Working Group and the Australia & New Zealand Mycology Interest Group (ANZMIG) webinar.
Dr Abby Douglas is an invited expert panelist!
Wednesday, May 28
7:00 PM – 8:30 PM AEST
Fungus in a Joint – Osteoarticular Infections
Register here: bit.ly/FFAP2025
Happy Infectious Diseases Pharmacists Day to my colleagues, mentors, and clinician-researcher heroes #IDPharmacistsDay #SIDPAdvocacy @adphaau.bsky.social @sidpharm.bsky.social @ncicancer.bsky.social
We are proud to share that the amazing Antibiotic Allergy Nursing Team has been nominated for the @petermaccc.bsky.social Annual Nursing Awards in celebration of International Nurses Day. Well done team!
Day 2 of the @petermaccc.bsky.social Research Symposium opened with A/Prof @michyong.bsky.social plenary on "Transforming the care of Infectious Diseases in Cancer Patients." Discussing groundbreaking research and future directions in fungal, viral, bacterial, and vaccine clinical trials.
Happy Friday!
The latest NCIC Newsletter is out now. Catch up on key updates and news.
Check it out here: cancerandinfections.org/newsletter
NCIC Fellow A/Prof Michelle Yong giving us all a great lesson in the complexities of viral infection post transplant #escmidglobal
Another head scratcher case for Monica and Dimitrios #escmidglobal
Prof Slavin discussing a very unusual case #escmidglobal Clinical grand rounds
NCIC fellow Dr Abby Douglas and next gen sequencing have found many ICH pts have previously undetected viruses (incl pegiviruses) that are associated with worse outcomes. Markers of overall immunosuppression or causative??#escmidglobal
